Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
Yulino Castillo-Núñez, Paloma Almeda‐Valdés, Guillermo González-Gálvez, et al.
Current Diabetes Reports (2024) Vol. 24, Iss. 7, pp. 158-166
Closed Access | Times Cited: 9

Showing 9 citing articles:

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Haixiang Zheng, Leonardo A. Sechi, Eliano Pio Navarese, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Lean MASLD and Cardiovascular Disease: A Review
Nachum Lebovics, Gabriel Heering, William H. Frishman, et al.
Cardiology in Review (2025)
Closed Access
Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population
Satoshi Sato, Chikara Iino, K. Furusawa, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2013-2013
Open Access
Metabolic syndrome traits differentially and cumulatively influence micro‐ and macrovascular disease risk in patients with MASLD
Alex E. Henney, David R. Riley, Theresa Hydes, et al.
Liver International (2024) Vol. 44, Iss. 11, pp. 3031-3049
Open Access | Times Cited: 2
From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status
Andrea Boccatonda, Damiano D’Ardes, Veronica Moronti, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1781-1781
Open Access | Times Cited: 1
Exploring the Th2 Response in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Potential Modulator of the Renin-Angiotensin System (RAS) Pathway in Hypertension Development
Lucia A. Méndez‐García, Galileo Escobedo, Itzel Baltazar-Pérez, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1080-1080
Open Access
Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease
Tatjána Ábel, Béla Benczúr, Éva Csajbókné Csobod
Frontiers in Medicine (2024) Vol. 11
Open Access
Metabolic dysfunction-associated fatty liver disease: bridging cardiology and hepatology
Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, et al.
Cardiology Plus (2024)
Open Access
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Page 1

Scroll to top